Entero Healthcare Solutions' Q1 FY 2025-26 Quarterly Results

Result Summary

• Entero Healthcare Solutions Ltd reported a 35.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 26.9%.
• Its expenses for the quarter were up by 33.4% QoQ and 26.8% YoY.
• The net profit increased 42.7% QoQ and increased 47.2% YoY.
• The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 6.4 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Entero Healthcare Solutions Ltd is a company known for its operations within the healthcare sector. The company primarily focuses on the distribution and supply chain management of pharmaceutical products, medical devices, and other healthcare-related goods. As an integral player in the healthcare industry, Entero Healthcare Solutions Ltd aims to enhance the availability and accessibility of essential medical supplies through efficient logistics and supply chain operations. There are no specific recent developments provided in the data, and any further information on new products or strategic initiatives is not available in the given dataset.

Revenue

For the first quarter of the fiscal year 2026 (Q1FY26), Entero Healthcare Solutions Ltd reported a total income of ₹1409.64 crores. This marks a significant increase of 35.1% compared to the previous quarter (Q4FY25), where the total income was ₹1043.32 crores. Year-over-year, the total income grew by 26.9% from ₹1110.47 crores in Q1FY25. These figures highlight a notable upward trend in the company's revenue generation over both the quarterly and annual periods examined.

Profitability

In terms of profitability, Entero Healthcare Solutions Ltd recorded a profit before tax of ₹36.36 crores in Q1FY26, which is a substantial rise of 168.1% from the ₹13.56 crores recorded in the previous quarter (Q4FY25). Year-over-year, this represents an increase of 33.2% from ₹27.30 crores in Q1FY25. After accounting for taxes, the profit after tax stood at ₹30.23 crores in Q1FY26, up 42.7% from ₹21.18 crores in Q4FY25, and a 47.2% increase from ₹20.53 crores in Q1FY25. The earnings per share (EPS) also improved, reaching ₹6.40 in Q1FY26, up from ₹5.70 in Q4FY25 and ₹4.60 in Q1FY25, reflecting a YoY growth of 39.1%.

Operating Metrics

The total expenses for Entero Healthcare Solutions Ltd in Q1FY26 amounted to ₹1373.28 crores, an increase of 33.4% from the previous quarter's expenses of ₹1029.76 crores. On a year-over-year basis, expenses rose by 26.8% from ₹1083.17 crores in Q1FY25. Notably, the tax component in Q1FY26 was ₹6.13 crores, which contrasts with a tax credit of ₹-7.62 crores in Q4FY25, and was slightly lower than the ₹6.77 crores in Q1FY25, indicating a YoY decrease of 9.5%. These operating metrics provide insights into the cost structure and tax implications for the company during the periods under review.